| Identification | Back Directory | [Name]
1,4-Benzodioxin-5-carboxamide, 2,3-dihydro-7-[5-(4-morpholinyl)-7-oxo-7H-thieno[3,2-b]pyran-3-yl]-N-(3-pyridinylmethyl)- | [CAS]
2735720-80-4 | [Synonyms]
1,4-Benzodioxin-5-carboxamide, 2,3-dihydro-7-[5-(4-morpholinyl)-7-oxo-7H-thieno[3,2-b]pyran-3-yl]-N-(3-pyridinylmethyl)- | [Molecular Formula]
C26H23N3O6S | [MOL File]
2735720-80-4.mol | [Molecular Weight]
505.54 |
| Hazard Information | Back Directory | [Description]
SRX3212 is a Novel BRD4/PI3Kα inhibitor, displaying an IC50 of 3.7 nM toward BRD4BD1 and 32 nM toward BRD4BD2, and therefore was~65-fold more potent inhibitor of BRD4BD1 and~48-fold more potent inhibitor of BRD4BD2 than SF2523 (GLXC-10641), retaining its high inhibitory activity for PI3Kα (IC50: 22 nM). |
|
|